2-[18F]FDG PET identifies metabolic substrates of sudden cardiac death in hypertrophic cardiomyopathy
Open Access
- 21 November 2025
- journal article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 41298
Abstract
Risk stratification for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HCM) remains challenging. Enhanced imaging techniques could improve prognostic accuracy. This study investigates myocardial resting perfusion and metabolism using [13N]-NH3 and 2-[18F]FDG PET/CT and their correlation with HCM SCD risk scores. Thirty non-obstructive HCM patients (mean age 54 years, 57% male) with a mean SCD risk score of 3.7 ± 2.5% were evaluated. Myocardial 2-[18F]FDG metabolism and rest [13N]-NH3 perfusion PET/CT were analyzed. Hypermetabolism (2-[18F]FDG uptake with normal perfusion) occurred in 53% of cases (mean extension 11.8 ± 17.2%), while fibrosis (reduced perfusion without 2-[18F]FDG uptake) averaged 10.3 ± 10.2%. Mean rest myocardial blood flow (MBF) was 0.75 ± 0.21 ml/min/g, increasing with hypermetabolism extension (0.83 ± 0.32 ml/min/g for ≥ 20%, p = 0.019) but decreasing with SCD scores ≥ 6% (0.58 ± 0.05 ml/min/g, p = 0.034). Hypermetabolism correlated moderately with SCD risk scores (rho = 0.38, p = 0.036), with hypermetabolism peaking at intermediate risk (23.5 ± 27.1%) before declining. Fibrosis extension consistently increased with SCD risk (rho = 0.38, p = 0.039). In conclusion, our findings identify important correlations between myocardial hypermetabolism and fibrosis and SCD risk in HCM. Hypermetabolism peaks in intermediate-risk patients, reflecting earlier disease stages, while fibrosis increases with higher SCD risk, signaling disease progression and structural damage.Keywords
This publication has 35 references indexed in Scilit:
- Quantitative Assessment of Cardiac Hypermetabolism and Perfusion for Diagnosis of Cardiac SarcoidosisJournal of Nuclear Cardiology, 2020
- Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk ScoreThe American Journal of Cardiology, 2019
- Occasionally increased 18F-FDG uptake in apical hypertrophic cardiomyopathy on serial follow-up PET/CTJournal of Nuclear Cardiology, 2019
- Is there a role for cardiac positron emission tomography in hypertrophic cardiomyopathy?Journal of Nuclear Cardiology, 2018
- Incidental spade-shaped FDG uptake in the left ventricular apex suggests apical hypertrophic cardiomyopathyAnnals of Nuclear Medicine, 2017
- Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanismsJournal of Nuclear Cardiology, 2016
- Cardiac imaging with 18F-fluorodeoxyglucose PET/MRI in hypertrophic cardiomyopathyJournal of Nuclear Cardiology, 2016
- Myocardial Fibrosis in Hypertrophic Cardiomyopathy Demonstrated by Integrated Cardiac F-18 FDG PET/MRNuclear Medicine and Molecular Imaging, 2013
- Myocardial glucose metabolism in patients with hypertrophic cardiomyopathy: Assessment by F-18-FDG PET studyAnnals of Nuclear Medicine, 1998
- Differences in myocardial fluoro-18 2-deoxyglucose uptake in young versus older patients with hypertrophic cardiomyopathyThe American Journal of Cardiology, 1992